| Title : Advances in prodrug design for Alzheimer's disease: the state of the art - Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| Author(s) : Travers-Lesage V , Mignani SM , Dallemagne P , Rochais C |
| Ref : Expert Opin Drug Discov , 17 :325 , 2022 |
| Abstract : |
| PubMedSearch : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| PubMedID: 35089846 |
| Title : Advances in prodrug design for Alzheimer's disease: the state of the art - Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| Author(s) : Travers-Lesage V , Mignani SM , Dallemagne P , Rochais C |
| Ref : Expert Opin Drug Discov , 17 :325 , 2022 |
| Abstract : |
| PubMedSearch : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| PubMedID: 35089846 |
| Title : Advances in prodrug design for Alzheimer's disease: the state of the art - Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| Author(s) : Travers-Lesage V , Mignani SM , Dallemagne P , Rochais C |
| Ref : Expert Opin Drug Discov , 17 :325 , 2022 |
| Abstract : |
| PubMedSearch : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325 |
| PubMedID: 35089846 |